Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance

[1]  Thea D. Tlsty,et al.  A framework for advancing our understanding of cancer-associated fibroblasts , 2020, Nature Reviews Cancer.

[2]  Jene Choi,et al.  Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses , 2019, Scientific Reports.

[3]  R. Hass,et al.  Involvement of Actin Cytoskeletal Components in Breast Cancer Cell Fusion with Human Mesenchymal Stroma/Stem-Like Cells , 2019, International journal of molecular sciences.

[4]  Shinji Iizuka,et al.  Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival , 2018, Science Advances.

[5]  Zhenqiu Liu,et al.  Heterogeneous cancer associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner , 2018, Oncogene.

[6]  S. K. Zaidi,et al.  Epithelial‐to‐mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity , 2018, Journal of cellular physiology.

[7]  Y. Ohyama,et al.  Potential factors influencing the development of oral tongue squamous cell carcinoma in young mature patients: Lingual position of the mandibular second molar and narrow tongue space , 2017, Oncology letters.

[8]  A. Philip,et al.  CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma , 2017, Oncotarget.

[9]  Yu-Ling Wu,et al.  Mesenchymal stem cell‐derived CCN2 promotes the proliferation, migration and invasion of human tongue squamous cell carcinoma cells , 2017, Cancer science.

[10]  Jiwei Yu,et al.  Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway , 2016, Tumor Biology.

[11]  A. Ahmadzadeh,et al.  Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells , 2016, Tumor Biology.

[12]  Yongmin Yan,et al.  Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer , 2015, Cell cycle.

[13]  L. Cosmi,et al.  Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation , 2015, British Journal of Cancer.

[14]  H. Yokozaki,et al.  Regulated genes in mesenchymal stem cells and gastric cancer. , 2015, World journal of stem cells.

[15]  Kyung-Ja Cho,et al.  Epithelial-Mesenchymal Transition , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[16]  Christian M. Metallo,et al.  Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. , 2014, Cancer cell.

[17]  Annette Meeson,et al.  Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. , 2014, Cancer treatment reviews.

[18]  L. Blavier,et al.  Bone Marrow–Derived Mesenchymal Stromal Cells Promote Survival and Drug Resistance in Tumor Cells , 2014, Molecular Cancer Therapeutics.

[19]  J. Vuoristo,et al.  Human Bone Marrow Mesenchymal Stem Cells Induce Collagen Production and Tongue Cancer Invasion , 2013, PloS one.

[20]  Kenneth J. Pienta,et al.  Recruitment of Mesenchymal Stem Cells Into Prostate Tumors Promotes Metastasis , 2013, Nature Communications.

[21]  Devang M Patel,et al.  Therapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine , 2013, Stem cells international.

[22]  A. Karnoub,et al.  Lysyl Oxidase at the Crossroads of Mesenchymal Stem Cells and Epithelial-Mesenchymal Transition , 2013, Oncotarget.

[23]  Q. Ye,et al.  Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models. , 2013, Oncology reports.

[24]  Ruth S. Waterman,et al.  Anti‐Inflammatory Mesenchymal Stem Cells (MSC2) Attenuate Symptoms of Painful Diabetic Peripheral Neuropathy , 2012, Stem cells translational medicine.

[25]  G. Rappa,et al.  Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. , 2012, The American journal of pathology.

[26]  E. Voest,et al.  The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression , 2012, British Journal of Cancer.

[27]  P. Pauwels,et al.  Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling , 2012, Gut.

[28]  Z. Ju,et al.  Fusion of human umbilical cord mesenchymal stem cells with esophageal carcinoma cells inhibits the tumorigenicity of esophageal carcinoma cells. , 2011, International journal of oncology.

[29]  E. Genden,et al.  Head and neck squamous cell carcinoma: new translational therapies. , 2010, The Mount Sinai journal of medicine, New York.

[30]  N. Bhowmick,et al.  Bone Marrow Derived Mesenchymal Stem Cells Incorporate into the Prostate during Regrowth , 2010, PloS one.

[31]  J. Gimble,et al.  Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. , 2010, Current Stem Cell Research & Therapy.

[32]  M. Andreeff,et al.  Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.

[33]  Y. Mao,et al.  DUAL‐TARGETED ANTITUMOR EFFECTS AGAINST BRAINSTEM GLIOMA BY INTRAVENOUS DELIVERY OF TUMOR NECROSIS FACTOR‐RELATED, APOPTOSIS‐INDUCING, LIGAND‐ENGINEERED HUMAN MESENCHYMAL STEM CELLS , 2009, Neurosurgery.

[34]  Gang Li,et al.  Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. , 2009, Cancer letters.

[35]  Y. Verma,et al.  Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine , 2009, Journal of cellular and molecular medicine.

[36]  P. Ruggerone,et al.  Copper-1,10-phenanthroline complexes binding to DNA: structural predictions from molecular simulations. , 2009, Journal of Physical Chemistry B.

[37]  D. Davies,et al.  Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. , 2009, Cancer research.

[38]  E. Karapanagiotou,et al.  Head and neck cancer in the elderly: an overview on the treatment modalities. , 2009, Cancer treatment reviews.

[39]  M. Karamouzis,et al.  Head and neck cancer , 2008, The Lancet.

[40]  S. Choi,et al.  Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy , 2008, Journal of dental research.

[41]  C. Ragin,et al.  The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus , 2007, Journal of dental research.

[42]  M. Raffeld,et al.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma , 2006, The Journal of experimental medicine.

[43]  A. Rizvi,et al.  Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[44]  V. Brower.  Search and destroy: recent research exploits adult stem cells' attraction to cancer. , 2005, Journal of the National Cancer Institute.

[45]  M. Andreeff,et al.  Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. , 2004, Journal of the National Cancer Institute.

[46]  I. Bellantuono,et al.  A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. , 2004, Blood.

[47]  M. Lindvall,et al.  Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. , 2003, Experimental and molecular pathology.

[48]  S. Hayward,et al.  Malignant transformation in a nontumorigenic human prostatic epithelial cell line. , 2001, Cancer research.

[49]  A. Gomes,et al.  Etiologic factors associated with oral squamous cell carcinoma in non-smokers and non-alcoholic drinkers: a brief approach. , 2012, Brazilian dental journal.

[50]  Ruud H. Brakenhoff,et al.  The molecular biology of head and neck cancer , 2011, Nature Reviews Cancer.

[51]  M. Andreeff,et al.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.

[52]  A. Argiris,et al.  Epidemiology, staging, and screening of head and neck cancer. , 2003, Cancer treatment and research.

[53]  F. Djouad,et al.  Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. , 2003, Blood.